NCT01830881View on ClinicalTrials.gov

Evaluation of Oral Midazolam in First-trimester Surgical Abortions

PHASE4CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2014

Conditions
PainAnxietyNausea
Interventions
DRUG

Midazolam

5 mL oral midazolam oral syrup (2 mg/mL) 30-60 minutes prior to procedure

DRUG

Ibuprofen

800 mg oral ibuprofen 30-60 minutes prior to procedure

OTHER

Placebo-Cherry syrup

5 mL oral placebo-cherry syrup 30-60 minutes prior to procedure

DRUG

Lidocaine

injection of 20 mL 1% lidocaine without epinephrine

Trial Locations (1)

97206

Planned Parenthood Columbia Willamette, Portland

All Listed Sponsors
lead

Oregon Health and Science University

OTHER

NCT01830881 - Evaluation of Oral Midazolam in First-trimester Surgical Abortions | Biotech Hunter | Biotech Hunter